Picropodophyllin (PPP) is a potent rhabdomyosarcoma growth inhibitor both in vitro and in vivo
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Picropodophyllin (PPP) is a potent rhabdomyosarcoma growth inhibitor both in vitro and in vivo ; volume:17 ; number:1 ; day:9 ; month:8 ; year:2017 ; pages:1-11 ; date:12.2017
BMC cancer ; 17, Heft 1 (9.8.2017), 1-11, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Tarnowski, Maciej
- Beteiligte Personen und Organisationen
-
Tkacz, Marta
Zgutka, Katarzyna
Bujak, Joanna
Kopytko, Patrycja
Pawlik, Andrzej
SpringerLink (Online service)
- DOI
-
10.1186/s12885-017-3495-y
- URN
-
urn:nbn:de:1111-2017102612026
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tarnowski, Maciej
- Tkacz, Marta
- Zgutka, Katarzyna
- Bujak, Joanna
- Kopytko, Patrycja
- Pawlik, Andrzej
- SpringerLink (Online service)
Ähnliche Objekte (12)
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma
PPP
P.P.P.
![[Lll-Ppp]](https://iiif.deutsche-digitale-bibliothek.de/image/2/a89b8d26-1e48-46c2-8930-1ea66eb0ca1d/full/!306,450/0/default.jpg)
[Lll-Ppp]
Lit. PPP
![[Lll-Ppp]](https://iiif.deutsche-digitale-bibliothek.de/image/2/c8b92aa5-d3a4-475a-ab24-1d0a84a27204/full/!306,450/0/default.jpg)
[Lll-Ppp]
Improving Therapies of Rhabdomyosarcoma
Neonatal Chest Wall Rhabdomyosarcoma
Potent and selective ABCG2 inhibitors derived from tariquidar
Potent and selective ABCG2 inhibitors derived from tariquidar
Potent and specific MTH1 inhibitors targeting gastric cancer
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma
PPP
P.P.P.
[Lll-Ppp]
Lit. PPP
[Lll-Ppp]
Improving Therapies of Rhabdomyosarcoma
Neonatal Chest Wall Rhabdomyosarcoma
Potent and selective ABCG2 inhibitors derived from tariquidar
Potent and selective ABCG2 inhibitors derived from tariquidar
Potent and specific MTH1 inhibitors targeting gastric cancer
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma
PPP
P.P.P.
[Lll-Ppp]
Lit. PPP
[Lll-Ppp]
Improving Therapies of Rhabdomyosarcoma
Neonatal Chest Wall Rhabdomyosarcoma
Potent and selective ABCG2 inhibitors derived from tariquidar
Potent and selective ABCG2 inhibitors derived from tariquidar
Potent and specific MTH1 inhibitors targeting gastric cancer